Newsletter

Impact of Brexit on Pharma Space
How the exit of UK has impacted the pharma and healthcare market in the UK and overall

Impact of Brexit on Pharma Space


The Union of the European countries, also known as the European Union or the EU, is more or less like a conglomerate of countries. These countries make up the whole continent. The economic and political ties that EU countries share were fostered after the end of World War II. Since then, the EU has been considered as a single market. This was taken in a positive light, but lately, this forced camaraderie had come under the scanner when Britain voted to leave the Union.

BREXIT, the ‘EXIT’ of ‘BRITAIN’ from ‘EUROPEAN UNION’, shook the whole world when the United Kingdom voted in favour of leaving the EU.

The provision of BREXIT was carried out by the European Union Referendum Act 2015 (c 36), which is an Act of the Parliament of the UK. This referendum was created to provide a legal provision for the United Kingdom of Great Britain and Northern Ireland and Gibraltar to choose to remain or leave the membership of the European Union.

The whitepaper covers the Journey right from the EU referendum and the need for Brexit listing Implications of the Brexit on the pharma market in different regions, Economic consequences in the UK. The most significant uncertainty the pharmaceutical industry is facing if the UK were to leave the EU is the impact on regulatory processes and market authorisation of drugs in the UK.

Inside the Report:

More Newsletters

Cancer Globally (Vol. 1, Issue 1) Newsletter
Cancer Globally (Vol. 1, Issue 1)

Cancer has gripped the human society in its clutches in such a way that there has been many advancements to treat the same, but with little success.

Fragile X Syndrome Newsletter
Fragile X Syndrome

Fragile X Syndrome is a syndrome, which results in intellectual disabilities as well as affects the physical characteristics of the people..

Cutaneous Lupus Erythematosus Newsletter
Cutaneous Lupus Erythematosus

An autoimmune disease in which the immune system attacks its healthy skin, Cutaneous Lupus Erythematosus, belongs to the family of..

Gaucher Disease Newsletter
Gaucher Disease

The most common lysosomal disease, Gaucher Disease is a result of lack of sufficient glucocerebrosidase (GCase), an enzyme required..

Pompe disease Newsletter
Pompe disease

An autosomal metabolic disorder – Pompe disease results in deterioration of organs and tissues as a consequence of excess accumulation of glycogen..